KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$5.20 USD
-0.55 (-9.57%)
Updated Jun 18, 2024 04:00 PM ET
After-Market: $5.25 +0.05 (0.96%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Brokerage Reports
KALA BIO, Inc. [KALA]
Reports for Purchase
Showing records 241 - 260 ( 366 total )
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Plenty of Cash to Cover Key Catalysts; Next: Resubmission of DED NDA in Q2
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Impressive DED Phase 3 Results: NDA Resubmission in Q2; We Anticipate Approval
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
4Q19 and Full-Year 2019 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Q4 FY19; INVELTYS Sales Continue to Grow; STRIDE 3 Dry Eye Data in Late Q1
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
STRIDE 3 Dry Eye Study Completes Enrollment; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: KALA BIO, Inc.
Industry: Medical - Biomedical and Genetics
STRIDE 3 Enrolled Top-line Data in Q1:20; NDA Resubmission Expected in H1:20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L